Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia
Pre and post availability of direct acting antiviral therapy
Dados Bibliográficos
| ID | 14909694 |
|---|---|
| Autores | Jenny Iversen (0000-0002-0062-7300, UNSW Sydney, autor correspondente), Gregory J Dore (0000-0002-4741-2622, UNSW Sydney), Mitchell Starr (0000-0001-9521-7496, St Vincent's Hospital Sydney), Beth Catlett (0000-0003-3803-5391, UNSW Sydney), Philip Cunningham (0000-0003-2613-6910, St Vincent's Hospital Sydney), Louise Geddes (0000-0002-4706-0014, UNSW Sydney), Lisa Maher (0000-0001-6020-6519, UNSW Sydney) |
| Ano | 2020 |
| Volume | 83 |
| Páginas | 102837 |
| Data de publicação | 2020-09-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | International Journal of Drug Policy (JOURNAL) |
| Identificadores do periódico | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2020.102837 |
| PMID | 32645585 |
| OpenAlex | W3040291484 |
| Idioma | EN |
| Citações recebidas | 6 |
| Referências citadas | 37 |
Antiviral therapy · Chronic hepatitis · Environmental health · Hepatitis C · Hepatitis C virus · Population · Psychiatry · Syringe · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Internal Medicine · Virology
Epidemiology of acute infections in people who inject drugs in Australia
Concordance between self‐reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia
Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals
Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey
Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland
Hepatitis C virus treatment for prevention among people who inject drugs
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996–2015
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia
Reduction in HCV Incidence Among Injection Drug Users Attending Needle and Syringe Programs in Australia
| Obras citantes distintas | 6 |
|---|---|
| Citações por ano | 1,2 |
| Intervalo de citações | 2021 - 2025 (5) |
| Velocidade de citação | recent |
| Altamente citado | Não |
| Tipos de citação | Neutras: 6 |